1-(3-(2,4-dimethylthiazol-5-yl)-4-oxo-2,4-dihydroindeno[1,2-c]pyrazol-5-yl)-3-(4-methylpiperazin-1-yl)urea

This compound is a synthetic small molecule with the chemical formula C21H23N7O2S and a molecular weight of approximately 437.52 g/mol. It features an indeno[1,2-c]pyrazole core substituted with a dimethylthiazole group and a methylpiperazine-linked urea moiety. The compound is classified as experimental and has not been approved for any therapeutic use or entered clinical trials beyond preclinical investigation. Its mechanism of action is not well characterized in public databases; however, related indeno-pyrazole derivatives have been studied as potential kinase inhibitors or cell cycle modulators in cancer research due to their structural similarity to known cyclin-dependent kinase (CDK) inhibitors. No specific biological target or indication has been established for this molecule in the literature or major drug databases.

Other names

1-[3-(2,4-dimethylthiazol-5-yl)-4-oxo-2,4-dihydroindeno[1,2-c]pyrazol-5-yl]-3-(4-methylpiperazin-1-y)urea3-[3-(dimethyl-thiazolyl)-4‑oxo-indeno[1,2‑c]pyrazol‑5‑yl]-1-(4-methylpiperazin‑1‑yl)urea